• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消除A类清道夫受体不会影响表达人淀粉样蛋白前体的转基因小鼠中的淀粉样斑块形成或神经退行性变。

Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.

作者信息

Huang F, Buttini M, Wyss-Coray T, McConlogue L, Kodama T, Pitas R E, Mucke L

机构信息

Gladstone Institute of Neurological Disease, Department of Neurology, University of California, San Francisco, USA.

出版信息

Am J Pathol. 1999 Nov;155(5):1741-7. doi: 10.1016/S0002-9440(10)65489-2.

DOI:10.1016/S0002-9440(10)65489-2
PMID:10550330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1866996/
Abstract

The class A scavenger receptor (SR) is expressed on reactive microglia surrounding cerebral amyloid plaques in Alzheimer's disease (AD). Interactions between the SR and amyloid beta peptides (Abeta) in microglial cultures elicit phagocytosis of Abeta aggregates and release of neurotoxins. To assess the role of the SR in amyloid clearance and Abeta-associated neurodegeneration in vivo, we used the platelet-derived growth factor promoter to express human amyloid protein precursors (hAPPs) in neurons of transgenic mice. With increasing age, hAPP mice develop AD-like amyloid plaques. We bred heterozygous hAPP (hAPP(+/-)) mice that were wild type for SR (SR(+/+)) with SR knockout (SR(-/-)) mice. Crosses among the resulting hAPP(+/-)SR(+/-) offspring yielded hAPP(+/-) and hAPP(-/-) littermates that were SR(+/+) or SR(-/-). These second-generation mice were analyzed at 6 and 12 months of age for extent of cerebral amyloid deposition and loss of synaptophysin-immunoreactive presynaptic terminals. hAPP(-/-)SR(-/-) mice showed no lack of SR expression, plaque formation, or synaptic degeneration, indicating that lack of SR expression does not result in significant accumulation of endogenous amyloidogenic or neurotoxic factors. In hAPP(+/-) mice, ablation of SR expression did not alter number, extent, distribution, or age-dependent accumulation of plaques; nor did it affect synaptic degeneration. Our results do not support a critical pathogenic role for microglial SR expression in neurodegenerative alterations associated with cerebral beta amyloidosis.

摘要

A类清道夫受体(SR)在阿尔茨海默病(AD)中围绕脑淀粉样斑块的反应性小胶质细胞上表达。小胶质细胞培养物中SR与淀粉样β肽(Aβ)之间的相互作用引发Aβ聚集体的吞噬作用和神经毒素的释放。为了评估SR在体内淀粉样蛋白清除和Aβ相关神经退行性变中的作用,我们使用血小板衍生生长因子启动子在转基因小鼠的神经元中表达人淀粉样蛋白前体(hAPPs)。随着年龄的增长,hAPP小鼠会出现类似AD的淀粉样斑块。我们将SR为野生型(SR(+/+))的杂合hAPP(hAPP(+/-))小鼠与SR基因敲除(SR(-/-))小鼠进行杂交。所得hAPP(+/-)SR(+/-)后代之间的杂交产生了SR(+/+)或SR(-/-)的hAPP(+/-)和hAPP(-/-)同窝小鼠。在6个月和12个月龄时对这些第二代小鼠进行分析,以检测脑淀粉样蛋白沉积程度和突触素免疫反应性突触前终末的丧失情况。hAPP(-/-)SR(-/-)小鼠未表现出SR表达缺失、斑块形成或突触变性,这表明SR表达缺失不会导致内源性淀粉样生成或神经毒性因子的显著积累。在hAPP(+/-)小鼠中,SR表达的缺失并未改变斑块的数量、程度、分布或年龄依赖性积累;也未影响突触变性。我们的结果不支持小胶质细胞SR表达在与脑β淀粉样变性相关的神经退行性改变中起关键致病作用。

相似文献

1
Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.消除A类清道夫受体不会影响表达人淀粉样蛋白前体的转基因小鼠中的淀粉样斑块形成或神经退行性变。
Am J Pathol. 1999 Nov;155(5):1741-7. doi: 10.1016/S0002-9440(10)65489-2.
2
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.野生型人淀粉样蛋白前体转基因小鼠中β淀粉样蛋白1-42的高水平神经元表达:无斑块形成的突触毒性。
J Neurosci. 2000 Jun 1;20(11):4050-8. doi: 10.1523/JNEUROSCI.20-11-04050.2000.
3
Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.人载脂蛋白E对转基因小鼠中阿尔茨海默病样突触和胆碱能缺陷的调节作用取决于亚型、衰老以及β淀粉样肽的过表达,而与斑块形成无关。
J Neurosci. 2002 Dec 15;22(24):10539-48. doi: 10.1523/JNEUROSCI.22-24-10539.2002.
4
Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.人类α1-抗糜蛋白酶在星形胶质细胞中的表达增强了淀粉样蛋白前体转基因小鼠的阿尔茨海默氏样病理变化。
Am J Pathol. 2000 Dec;157(6):2003-10. doi: 10.1016/s0002-9440(10)64839-0.
5
Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice.慢性 apocynin 处理可减轻 hAPP(751)(SL) 小鼠的β淀粉样斑块大小和小胶质细胞数量。
PLoS One. 2011;6(5):e20153. doi: 10.1371/journal.pone.0020153. Epub 2011 May 31.
6
Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.清道夫受体 B 类 I 型(SR-BI)调节血管周巨噬细胞并修饰阿尔茨海默病小鼠模型中的淀粉样蛋白病理。
Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20816-21. doi: 10.1073/pnas.1005888107. Epub 2010 Nov 12.
7
Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain.正常成年小鼠和人类大脑以及阿尔茨海默病大脑中星形胶质细胞和血管平滑肌细胞对I型B类清道夫受体的表达。
Am J Pathol. 2001 Mar;158(3):825-32. doi: 10.1016/S0002-9440(10)64030-8.
8
CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.CD36是一种B类清道夫受体,在阿尔茨海默病患者大脑的小胶质细胞上表达,并且能够介导活性氧的产生以响应β-淀粉样纤维。
Am J Pathol. 2002 Jan;160(1):101-12. doi: 10.1016/s0002-9440(10)64354-4.
9
Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.小胶质细胞 Trem2 在早期诱导突触损伤,并在 APP/PS1 小鼠的晚期防止淀粉样蛋白沉积。
FASEB J. 2019 Sep;33(9):10425-10442. doi: 10.1096/fj.201900527R. Epub 2019 Jun 20.
10
Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice.在人淀粉样前体蛋白转基因小鼠中,Fyn激酶调节突触毒性,但不调节异常发芽。
J Neurosci. 2004 May 12;24(19):4692-7. doi: 10.1523/JNEUROSCI.0277-04.2004.

引用本文的文献

1
Unraveling the complex role of microglia in Alzheimer's disease: amyloid β metabolism and plaque formation.解析小胶质细胞在阿尔茨海默病中的复杂作用:淀粉样β蛋白代谢与斑块形成
Inflamm Regen. 2025 May 30;45(1):16. doi: 10.1186/s41232-025-00383-4.
2
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.用于针对小胶质细胞和抑制阿尔茨海默病病理学中神经炎症的纳米技术。
Transl Neurodegener. 2024 Jan 4;13(1):2. doi: 10.1186/s40035-023-00393-7.
3
Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.恢复可溶性淀粉样前体蛋白α的功能作为阿尔茨海默病的一种潜在治疗方法。
J Neurosci Res. 2017 Apr;95(4):973-991. doi: 10.1002/jnr.23823. Epub 2016 Aug 17.
4
Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer Disease.在阿尔茨海默病小鼠模型中,系统性中枢神经系统(CNS)靶向递送神经肽Y(NPY)可减少神经退行性变并增加神经前体细胞增殖。
J Biol Chem. 2016 Jan 22;291(4):1905-1920. doi: 10.1074/jbc.M115.678185. Epub 2015 Nov 30.
5
Innate immunity and neuroinflammation.先天免疫与神经炎症。
Mediators Inflamm. 2013;2013:342931. doi: 10.1155/2013/342931. Epub 2013 Jun 15.
6
Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure.体内铅暴露后 Tg-SWDI 转基因小鼠大脑中β-淀粉样蛋白沉积增加。
Toxicol Lett. 2012 Sep 3;213(2):211-9. doi: 10.1016/j.toxlet.2012.07.002. Epub 2012 Jul 11.
7
Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.小胶质细胞和巨噬细胞对β淀粉样肽的清除:清除什么、何时清除以及何处清除的问题
Future Neurol. 2012 Mar 1;7(2):165-176. doi: 10.2217/fnl.12.6.
8
Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease.外周给予靶向中枢神经系统的金属蛋白酶抑制剂可降低阿尔茨海默病小鼠模型的 Aβ毒性。
PLoS One. 2011 Jan 31;6(1):e16575. doi: 10.1371/journal.pone.0016575.
9
Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.清道夫受体 B 类 I 型(SR-BI)调节血管周巨噬细胞并修饰阿尔茨海默病小鼠模型中的淀粉样蛋白病理。
Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20816-21. doi: 10.1073/pnas.1005888107. Epub 2010 Nov 12.
10
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.长期的中性内肽酶基因转移与APP转基因小鼠细胞内β淀粉样蛋白水平降低及行为改善相关。
BMC Neurosci. 2008 Nov 12;9:109. doi: 10.1186/1471-2202-9-109.

本文引用的文献

1
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.人载脂蛋白E3或E4在Apoe基因敲除小鼠大脑中的表达:对神经退行性变的异构体特异性影响。
J Neurosci. 1999 Jun 15;19(12):4867-80. doi: 10.1523/JNEUROSCI.19-12-04867.1999.
2
Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.阿尔茨海默病小鼠模型中与斑块无关的神经回路破坏
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33. doi: 10.1073/pnas.96.6.3228.
3
Abeta associated neuropil changes: correlation with neuronal loss and dementia.β淀粉样蛋白相关的神经毡改变:与神经元丢失和痴呆的相关性。
J Neuropathol Exp Neurol. 1998 Dec;57(12):1122-30. doi: 10.1097/00005072-199812000-00003.
4
Neuron loss in APP transgenic mice.APP转基因小鼠中的神经元损失。
Nature. 1998 Oct 22;395(6704):755-6. doi: 10.1038/27351.
5
Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging.路易体变异型阿尔茨海默病的新皮质突触密度与Braak分期:与经典阿尔茨海默病及正常衰老的比较
J Neuropathol Exp Neurol. 1998 Oct;57(10):955-60. doi: 10.1097/00005072-199810000-00007.
6
Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation.α2-巨球蛋白与β-淀粉样肽结合并阻止原纤维形成。
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3275-80. doi: 10.1073/pnas.95.6.3275.
7
Economic research on Alzheimer disease: a review of the literature.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 6:135-45.
8
The costs and social burdens of Alzheimer disease: what can and should be done?阿尔茨海默病的成本与社会负担:能够且应该采取什么措施?
Alzheimer Dis Assoc Disord. 1997 Dec;11(4):181-3.
9
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.两种具有阿尔茨海默病样病理特征的淀粉样前体蛋白转基因小鼠模型。
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13287-92. doi: 10.1073/pnas.94.24.13287.
10
Comparison of two quantitative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer disease.
J Neuropathol Exp Neurol. 1997 Nov;56(11):1202-6. doi: 10.1097/00005072-199711000-00004.